Annual Total Debt
$2.74 M
+$699.00 K+34.25%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual total debt is $2.74 million, with the most recent change of +$699.00 thousand (+34.25%) on December 1, 2023.
- During the last 3 years, NBY annual total debt has risen by +$2.24 million (+444.73%).
- NBY annual total debt is now -32.28% below its all-time high of $4.05 million, reached on December 31, 2019.
Performance
NBY Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.26 M
-$748.00 K-37.21%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly total debt is $1.26 million, with the most recent change of -$748.00 thousand (-37.21%) on September 1, 2024.
- Over the past year, NBY quarterly total debt has dropped by -$1.74 million (-57.92%).
- NBY quarterly total debt is now -73.32% below its all-time high of $4.73 million, reached on September 30, 2019.
Performance
NBY Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
NBY Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +34.3% | -57.9% |
| 3 y3 years | +444.7% | -58.5% |
| 5 y5 years | +100.0% | -58.5% |
NBY Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +397.3% | -58.5% | +129.0% |
| 5 y | 5-year | -32.3% | +444.7% | -68.8% | +543.9% |
| alltime | all time | -32.3% | -100.0% | -73.3% | -100.0% |
NovaBay Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.26 M(-37.2%) |
| Jun 2024 | - | $2.01 M(-17.0%) |
| Mar 2024 | - | $2.42 M(-11.6%) |
| Dec 2023 | $2.74 M(+34.2%) | $2.74 M(-8.6%) |
| Sep 2023 | - | $3.00 M(-1.3%) |
| Jun 2023 | - | $3.04 M(+53.7%) |
| Mar 2023 | - | $1.98 M(-3.1%) |
| Dec 2022 | $2.04 M(+270.4%) | $2.04 M(-5.4%) |
| Sep 2022 | - | $2.16 M(-4.9%) |
| Jun 2022 | - | $2.27 M(-4.9%) |
| Mar 2022 | - | $2.39 M(+333.2%) |
| Dec 2021 | $551.00 K(+9.5%) | $551.00 K(+181.1%) |
| Sep 2021 | - | $196.00 K(-35.3%) |
| Jun 2021 | - | $303.00 K(-25.2%) |
| Mar 2021 | - | $405.00 K(-19.5%) |
| Dec 2020 | $503.00 K(-87.6%) | $503.00 K(-28.2%) |
| Sep 2020 | - | $701.00 K(-51.5%) |
| Jun 2020 | - | $1.44 M(-57.3%) |
| Mar 2020 | - | $3.38 M(-16.4%) |
| Dec 2019 | $4.05 M(>+9900.0%) | $4.05 M(-14.5%) |
| Sep 2019 | - | $4.73 M(+0.3%) |
| Jun 2019 | - | $4.72 M(+5.7%) |
| Mar 2019 | - | $4.46 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) |
| Jun 2016 | - | $524.00 K(-82.9%) |
| Mar 2016 | - | $3.06 M(+85.1%) |
| Dec 2015 | $1.66 M(>+9900.0%) | $1.66 M(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $42.00 K(-60.4%) |
| Dec 2010 | $106.00 K(-77.8%) | $106.00 K(-36.9%) |
| Sep 2010 | - | $168.00 K(-38.0%) |
| Jun 2010 | - | $271.00 K(-27.2%) |
| Mar 2010 | - | $372.00 K(-22.0%) |
| Dec 2009 | $477.00 K(-46.1%) | $477.00 K(-18.2%) |
| Sep 2009 | - | $583.00 K(-15.1%) |
| Jun 2009 | - | $687.00 K(-12.7%) |
| Mar 2009 | - | $787.00 K(-11.1%) |
| Dec 2008 | $885.00 K(+10.3%) | $885.00 K(-9.7%) |
| Sep 2008 | - | $980.00 K(-8.8%) |
| Jun 2008 | - | $1.07 M(+15.5%) |
| Mar 2008 | - | $931.00 K(+16.1%) |
| Dec 2007 | $802.00 K(>+9900.0%) | $802.00 K(+47.7%) |
| Sep 2007 | - | $543.00 K(-6.7%) |
| Jun 2007 | - | $582.00 K(+424.3%) |
| Mar 2007 | - | $111.00 K(>+9900.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00 |
| Dec 2004 | $0.00(0.0%) | - |
| Dec 2003 | $0.00 | - |
FAQ
- What is NovaBay Pharmaceuticals annual total debt?
- What is the all time high annual total debt for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual total debt year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly total debt year-on-year change?
What is NovaBay Pharmaceuticals annual total debt?
The current annual total debt of NBY is $2.74 M
What is the all time high annual total debt for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total debt is $4.05 M
What is NovaBay Pharmaceuticals annual total debt year-on-year change?
Over the past year, NBY annual total debt has changed by +$699.00 K (+34.25%)
What is NovaBay Pharmaceuticals quarterly total debt?
The current quarterly total debt of NBY is $1.26 M
What is the all time high quarterly total debt for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total debt is $4.73 M
What is NovaBay Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, NBY quarterly total debt has changed by -$1.74 M (-57.92%)